Researcher Profiles

Return to member profile

George P. Studzinski, MD, PhD

Publications since 2011

Wang, X. Harrison, J. S. Studzinski, G. P. Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination. J Steroid Biochem Mol Biol, In process, . (PMID: 26319201)

Studzinski, G. P. Harrison, J. S. Wang, X. Sarkar, S. Kalia, V. Danilenko, M. Prospect: "Vitamin D Control of Hematopoietic Cell Differentiation and Leukemia" J Cell Biochem, In process, . (PMID: 25694395)

Gocek, E. Studzinski, G. P. The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy. J Clin Med, 4:504-534, . (PMID: 26239344, PMCID: PMC4470153)

Yuzefpolskiy, Y. Baumann, F. M. Penny, L. A. Studzinski, G. P. Kalia, V. Sarkar, S. Vitamin D Receptor Signals Regulate Effector and Memory CD8 T Cell Responses to Infections in Mice. J Nutr, 144:2073-2082, . (PMID: 25320188)

Zheng, R. Wang, X. Studzinski, G. P. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPbeta expression through MEF2C. J Steroid Biochem Mol Biol, In process, . (PMID: 25448741)

Wang, X. Pesakhov, S. Harrison, J. S. Kafka, M. Danilenko, M. Studzinski, G. P. The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage. Exp Cell Res, In process, . (PMID: 25447310)

Wang, X. Pesakhov, S. Weng, A. Kafka, M. Gocek, E. Nguyen, M. Harrison, J. S. Danilenko, M. Studzinski, G. P. ERK 5/MAPK PATHWAY HAS A MAJOR ROLE IN 1alpha,25-(OH) VITAMIN D-INDUCED TERMINAL DIFFERENTIATION OF MYELOID LEUKEMIA CELLS. J Steroid Biochem Mol Biol, 144 Pt A:223-227, . (PMID: 24514755, PMCID: PMC4000286)

Wang, X. Pesakhov, S. Harrison, J. S. Danilenko, M. Studzinski, G. P. ERK5 Pathway Regulates Transcription Factors Important for Monocytic Differentiation of Human Myeloid Leukemia Cells. J Cell Physiol, 229:856-867, . (PMID: 24264602)

Gocek, E. Moulas, A. N. Studzinski, G. P. Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells. Crit Rev Clin Lab Sci, 51:125-137, . (PMID: 24446827)

Chen-Deutsch, X. Kutner, A. Harrison, J. S. Studzinski, G. P. The pan-caspase inhibitor Q-VD-OPh has anti-leukemia effects and can interact with vitamin D analogs to increase HPK1 signaling in AML cells. Leuk Res, 36:884-888, . (PMID: 22541691, PMCID: PMC3361643)

Gocek, E. Studzinski, G. P. Genes encoding transcription factors have self-control: how important is this for cell differentiation? Leuk Res, 36:672-674, . (PMID: 22424711)

Halicka, H. D. Zhao, H. Li, J. Traganos, F. Studzinski, G. P. Darzynkiewicz, Z. Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3. Aging (Albany NY), 4:270-278, . (PMID: 22498490, PMCID: PMC3371762)

Chen-Deutsch, X. Studzinski, G. P. Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1alpha,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance. Cell Cycle, 11:1364-1373, . (PMID: 22421156, PMCID: PMC3350877)

Studzinski, G. P. Brown, G. Danilenko, M. Hughes, P. Marcinkowska, E. Differentiation and cell survival of myeloid leukemia cells. Leuk Res Treatment, 2012:370375, . (PMID: 23259065, PMCID: PMC3504243)

Duggal, J. Harrison, J. S. Studzinski, G. P. Wang, X. Involvement of MicroRNA181a in Differentiation and Cell Cycle Arrest Induced by a Plant-derived Antioxidant Carnosic Acid and Vitamin D Analog Doxercalciferol in Human Leukemia Cells. Microrna, 1:26-33, . (PMID: 25048087)

Gocek, E. Wang, X. Liu, X. Liu, C. G. Studzinski, G. P. MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis. Cancer Res, 71:6230-6239, . (PMID: 21816906)

Wang, X. Studzinski, G. P. Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells. J Cell Physiol, 226:1232-1240, . (PMID: 20945381, PMCID: PMC3440184)

Bobilev, I. Novik, V. Levi, I. Shpilberg, O. Levy, J. Sharoni, Y. Studzinski, G. P. Danilenko, M. The Nrf2 transcription factor is a positive regulator of myeloid Differentiation of acute myeloid leukemia cells. Cancer Biol Ther, 11:317-329, . (PMID: 21099366, PMCID: PMC3047086)

Zhang, J. Harrison, J. S. Studzinski, G. P. Isoforms of p38MAPK gamma and delta contribute to differentiation of human AML cells induced by 1,25-dihydroxyvitamin D(3). Exp Cell Res, 317:117-130, . (PMID: 20804750, PMCID: PMC2998239)